PE-22-28 Dosage Guide

Complete guide to PE-22-28 dosing protocols, administration methods, and safety considerations for research purposes.

Research Use Only: The dosage information provided is for educational and research purposes. Peptides are not approved by the FDA for human use. Always consult with a healthcare professional.

Recommended Dosage

Research protocols vary. Intranasal dosing has been studied at various concentrations. Optimal human dosing not established.

Administration Method

Intranasal administration preferred for CNS delivery. Research compound with limited human use data.

Side Effects to Monitor

Very limited human data. Primarily studied in animal models for safety and efficacy.

Safety Considerations & Risks

Highly experimental. Most data from animal studies. Long-term effects completely unknown.